Iloprost in High Risk Cardiac Surgical Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Pulmonary Hypertension
Interventions
DRUG

Iloprost (Ventavis)

Twice 20 µg at day 0 (total dose 40 µg) intraoperatively

DRUG

Isotonic Sodium Chloride solution 0.9 % (placebo)

Twice at day 0 intraoperatively

Trial Locations (6)

13353

Deutsches Herzzentrum Berlin, Berlin

32545

Herz- und Diabeteszentrum NRW, Bad Oeynhausen

40225

Hospital of the university of Duesseldorf, Düsseldorf

52074

Hospital of the university of Aachen, Aachen

60590

Hospital of the university of Frankfurt, Frankfurt

81377

Hospital of the university of munich, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Algora

UNKNOWN

lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00927654 - Iloprost in High Risk Cardiac Surgical Patients | Biotech Hunter | Biotech Hunter